These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7535089)

  • 1. Loss of heterozygosity in sporadic primary cutaneous melanoma.
    Healy E; Rehman I; Angus B; Rees JL
    Genes Chromosomes Cancer; 1995 Feb; 12(2):152-6. PubMed ID: 7535089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
    Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
    Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
    Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
    Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 9 deletion in sporadic and familial melanomas in vivo.
    Isshiki K; Seng BA; Elder DE; Guerry D; Linnenbach AJ
    Oncogene; 1994 Jun; 9(6):1649-53. PubMed ID: 8183559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis.
    Takata M; Morita R; Takehara K
    Int J Cancer; 2000 Feb; 85(4):492-7. PubMed ID: 10699920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 10 allelic loss in malignant melanoma.
    Isshiki K; Elder DE; Guerry D; Linnenbach AJ
    Genes Chromosomes Cancer; 1993 Nov; 8(3):178-84. PubMed ID: 7509626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite analysis of melanoma lesions using (CA)13 oligonucleotides as an internal probe.
    Fujiwara Y; Hoon DS
    Int J Oncol; 2000 Oct; 17(4):783-7. PubMed ID: 10995892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression.
    Morita R; Fujimoto A; Hatta N; Takehara K; Takata M
    J Invest Dermatol; 1998 Dec; 111(6):919-24. PubMed ID: 9856796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
    Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
    Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
    Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
    Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
    Stark M; Hayward N
    Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of allelic losses in primary melanoma.
    Healy E; Belgaid C; Takata M; Harrison D; Zhu NW; Burd DA; Rigby HS; Matthews JN; Rees JL
    Oncogene; 1998 Apr; 16(17):2213-8. PubMed ID: 9619830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma.
    Walker GJ; Palmer JM; Walters MK; Nancarrow DJ; Parsons PG; Hayward NK
    Int J Cancer; 1994 Jul; 58(2):203-6. PubMed ID: 8026882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
    Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
    Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.
    Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS
    J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic analysis of primary and metastatic cutaneous melanoma.
    Rao UN; Jones MW; Finkelstein SD
    Cancer Genet Cytogenet; 2003 Jan; 140(1):37-44. PubMed ID: 12550756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
    Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
    Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.